ABSTRACT NUMBER: ESOC2026A1868 EARLY NEUROLOGICAL PROGRESSION IN ANTERIOR CHOROIDAL ARTERY INFARCTS AND ASSOCIATED FACTORS

Abstract Background and aims The clinical course and prognosis of anterior choroidal artery (ACHA) infarctions remain poorly defined. Early neurological deterioration (END), defined as an increase of four or more NIHSS points or two or more motor NIHSS points during hospitalization, represents key window for intervention. This study aims to identify biomarkers of END in ACHA infarcts. Methods We conducted a retrospective descriptive study including patients admitted to the neurovascular unit of Sahloul Hospital, Tunisia, for ACHA ischemic stroke, over a 33-month period.Clinical and radiological data were collected. Results Ninety patients were included (mean age 61.8 ± 0.5). END occurred in 18.8% (n = 17). Progressors had a significantly higher NIHSS score at discharge than non-progressors (8 ±3 vs. 4 ±3; p <0.001). Diabetes was the strongest predictor of END (p =0.026; OR =4.18). Radiologically, non-lacunar infarcts >15 mm were more frequent among progressors (p =0.064; OR=3.06) same as ipsilateral internal carotid stenosis (p=0.165, OR=2.908). In multivariate analysis, moderate-to-severe leukoaraiosis (Fazekas ≥ 2) independently predicted END (p= 0.04; OR =5.8), while hypertension was independently associated with a lower risk of progression (p=0.017; OR=0.124). Neither intravenous thrombolysis (p=0.160) nor clopidogrel loading (600 mg; p =1.000) reduced progression. Conclusions END occurs in nearly one-fifth of ACHA infarcts and is associated with worse outcomes. Diabetes is the main clinical predictor, while larger non-lacunar infarcts and advanced leukoaraiosis are key radiological markers. These findings support early risk stratification and closer monitoring, and suggest the need for further therapeutic studies. Conflict of interest Lina Bouafia : Nothing to disclose, Houssem Slimen : Nothing to disclose, Emna Jarrar : Nothing to disclose, Ahmed Mili : : Nothing to disclose, Khaoula Jeamii: : Nothing to disclose, Anise Hassine : Nothing to disclose, Salma Naija : Nothing to disclose, Sana Ben Amor : Nothing to discloseL

Authors

Institutions

Publication Details

Journal
European Stroke Journal
Published
2026-05-01
DOI
https://doi.org/10.1093/esj/aakag023.880
Primary Topic
Cerebrovascular and Carotid Artery Diseases
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

ABSTRACT NUMBER: ESOC2026A1868 EARLY NEUROLOGICAL PROGRESSION IN ANTERIOR CHOROIDAL ARTERY INFARCTS AND ASSOCIATED FACTORS

Salma Naija, H. Slimen, Khaoula Jemai, Sana Ben Amor et al.
European Stroke Journal
Cerebrovascular and Carotid Artery Diseases
article

ABSTRACT NUMBER: ESOC2026A1868 EARLY NEUROLOGICAL PROGRESSION IN ANTERIOR CHOROIDAL ARTERY INFARCTS AND ASSOCIATED FACTORS

Salma Naija, H. Slimen, Khaoula Jemai, Sana Ben Amor, Emna Jarrar, Anis Hassine, Lina Bouafia, Ahmed Mili
article en

Abstract

Abstract Background and aims The clinical course and prognosis of anterior choroidal artery (ACHA) infarctions remain poorly defined. Early neurological deterioration (END), defined as an increase of four or more NIHSS points or two or more motor NIHSS points during hospitalization, represents key window for intervention. This study aims to identify biomarkers of END in ACHA infarcts. Methods We conducted a retrospective descriptive study including patients admitted to the neurovascular unit of Sahloul Hospital, Tunisia, for ACHA ischemic stroke, over a 33-month period.Clinical and radiological data were collected. Results Ninety patients were included (mean age 61.8 ± 0.5). END occurred in 18.8% (n = 17). Progressors had a significantly higher NIHSS score at discharge than non-progressors (8 ±3 vs. 4 ±3; p <0.001). Diabetes was the strongest predictor of END (p =0.026; OR =4.18). Radiologically, non-lacunar infarcts >15 mm were more frequent among progressors (p =0.064; OR=3.06) same as ipsilateral internal carotid stenosis (p=0.165, OR=2.908). In multivariate analysis, moderate-to-severe leukoaraiosis (Fazekas ≥ 2) independently predicted END (p= 0.04; OR =5.8), while hypertension was independently associated with a lower risk of progression (p=0.017; OR=0.124). Neither intravenous thrombolysis (p=0.160) nor clopidogrel loading (600 mg; p =1.000) reduced progression. Conclusions END occurs in nearly one-fifth of ACHA infarcts and is associated with worse outcomes. Diabetes is the main clinical predictor, while larger non-lacunar infarcts and advanced leukoaraiosis are key radiological markers. These findings support early risk stratification and closer monitoring, and suggest the need for further therapeutic studies. Conflict of interest Lina Bouafia : Nothing to disclose, Houssem Slimen : Nothing to disclose, Emna Jarrar : Nothing to disclose, Ahmed Mili : : Nothing to disclose, Khaoula Jeamii: : Nothing to disclose, Anise Hassine : Nothing to disclose, Salma Naija : Nothing to disclose, Sana Ben Amor : Nothing to discloseL

European Stroke JournalVol. 11(Supplement_1)
Hôpital Sahloul (TN)
Good health and well-being
Openalex Percentile: Top 9%
Cerebrovascular and Carotid Artery Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.